Cipla (NSE:CIPLA) Change In Inventory : ₹0 Mil (TTM As of Sep. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Cipla Change In Inventory?

Cipla's change in inventory for the quarter that ended in Sep. 2024 was ₹0 Mil. It means Cipla's inventory stayed the same from Jun. 2024 to Sep. 2024 .

Cipla's change in inventory for the fiscal year that ended in Mar. 2024 was ₹-619 Mil. It means Cipla's inventory increased by ₹619 Mil from Mar. 2023 to Mar. 2024 .

Cipla's Total Inventories for the quarter that ended in Sep. 2024 was ₹55,729 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cipla's Days Inventory for the quarter that ended in Sep. 2024 was 111.37.

Inventory Turnover measures how fast the company turns over its inventory within a year. Cipla's Inventory Turnover for the quarter that ended in Sep. 2024 was 0.82.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cipla's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 0.40.

Cipla Change In Inventory Historical Data

The historical data trend for Cipla's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipla Change In Inventory Chart

Cipla Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Inventory

Get a 7-Day Free Trial

-3,315.50

-2,543.20

-6,211.10

1,107.70

-618.60

Cipla Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Cipla Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Cipla (NSE:CIPLA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cipla's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	27864.3	/	22830.1	*	365 / 4
	=	111.37

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cipla's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	22830.1	/	27864.3
	=	0.82

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cipla's Inventory to Revenue for the quarter that ended in Sep. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	27864.3	/	69612.2
	=	0.40

Cipla Change In Inventory Related Terms

Thank you for viewing the detailed overview of Cipla's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Cipla Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipla Ltd (NSE:CIPLA) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

500087:India

Address

Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013

Website

https://www.cipla.com

Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.

Cipla Headlines

No Headlines